Gadofosveset-enhanced MRI for the assessment of rectal cancer lymph nodes: Predictive criteria

Abdominal Imaging

Volumn 38, Issue 4, 2013, Pages 720-727

  Lambregts, Doenja M J ^a   Heijnen, Luc A ^a   Maas, Monique ^a   Rutten, Iris J G ^a   Martens, Milou H ^a   Backes, Walter H ^a   Riedl, Robert G ^a   Bakers, Frans C H ^a   Cappendijk, Vincent C ^a   Beets, Geerard L ^a   Beets Tan, Regina G H ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Contrast agents; Diagnostic imaging; Lymph nodes; Magnetic resonance imaging; Rectal neoplasms

Indexed keywords

GADOFOSVESET;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DRUG UPTAKE; FEMALE; HISTOLOGY; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE; LYMPH NODE METASTASIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTIVE VALUE; PRIORITY JOURNAL; RECTUM CANCER;

ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; FEMALE; GADOLINIUM; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84882261133     PISSN: 09428925     EISSN: 14320509     Source Type: Journal    
DOI: 10.1007/s00261-012-9957-4     Document Type: Article

References (17)

1. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638-646
2. Lezoche G, Baldarelli M, Guerrieri M, et al. (2008) A prospective randomized study with a 5-year minimum follow-up evaluation of transanal endoscopic microsurgery versus laparoscopic total mesorectal excision after neoadjuvant therapy. Surg Endosc 22:352-358
3. Habr-Gama A, Perez RO, Proscurshim I, et al. (2006) Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy. J Gastrointest Surg 10:1319-1328 (discussion 1328-1319)
4. Bipat S, Glas AS, Slors FJ, et al. (2004) Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging-a meta-analysis. Radiology 232:773-783
5. Lahaye MJ, Engelen SM, Nelemans PJ, et al. (2005) Imaging for predicting the risk factors - the circumferential resection margin and nodal disease - of local recurrence in rectal cancer: a meta-analysis. Semin Ultrasound CT MR 26:259-268
6. Will O, Purkayastha S, Chan C, et al. (2006) Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis. Lancet Oncol 7:52-60
7. Lahaye MJ, Engelen SM, Kessels AG, et al. (2008) USPIO-enhanced MR imaging for nodal staging in patients with primary rectal cancer: predictive criteria. Radiology 246:804-811
8. Koh D-M, Brown G, Temple L, et al. (2004) Rectal cancer: mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings - initial observations. Radiology 231:91-99
9. Lambregts DM, Beets GL, Maas M, et al. (2011) Accuracy of gadofosveset-enhanced MRI for nodal staging and restaging in rectal cancer. Ann Surg 253:539-545
10. Marijnen CA, Nagtegaal ID, Klein Kranenbarg E, et al. (2001) No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol 19:1976-1984
11. ®) enhanced MR lymph node detection: initial observations. Open Magn Resonance J 2:1-5
12. Wang C, Zhou Z, Wang Z, et al. (2005) Patterns of neoplastic foci and lymph node micrometastasis within the mesorectum. Langenbecks Arch Surg 390:312-318
13. Misselwitz B (2006) MR contrast agents in lymph node imaging. Eur J Radiol 58:375-382
14. Herborn CU, Lauenstein TC, Vogt FM, et al. (2002) Interstitial MR lymphography with MS-325: characterization of normal and tumor-invaded lymph nodes in a rabbit model. AJR Am J Roentgenol 179:1567-1572
15. Yamashita T, Takahara T, Kwee TC, et al. (2011) Diffusion magnetic resonance imaging with gadofosveset trisodium as a negative contrast agent for lymph node metastases assessment. Jpn J Radiol 29:25-32
16. Borschitz T, Wachtlin D, Mohler M, Schmidberger H, Junginger T (2008) Neoadjuvant chemoradiation and local excision for T2-3 rectal cancer. Ann Surg Oncol 15:712-720
17. Maas M, Beets-Tan RG, Lambregts DM, et al. (2011) Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol 29:4633-4640